- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/095 - OxytocinsVasopressinsRelated peptides
Patent holdings for IPC class A61K 38/095
Total number of patents in this class: 226
10-year publication summary
|
11
|
7
|
14
|
29
|
45
|
35
|
46
|
35
|
36
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ferring B.V. | 704 |
16 |
| Mallinckrodt Pharmaceuticals Ireland Ltd | 134 |
14 |
| ACADIA Pharmaceuticals Inc. | 204 |
8 |
| BIOVIE, Inc. | 28 |
6 |
| Levo Therapeutics, Inc. | 25 |
5 |
| Amryt Endo, Inc. | 49 |
5 |
| Endo Operations Limited | 358 |
5 |
| Monash University | 705 |
4 |
| Sunnybrook Research Institute | 229 |
4 |
| XOMA (US) LLC | 70 |
4 |
| OptiNose, Inc. | 87 |
4 |
| Novartis AG | 10974 |
3 |
| The Trustees of Columbia University in the City of New York | 3551 |
3 |
| Arecor Limited | 101 |
3 |
| Baylor College of Medicine | 935 |
3 |
| Centre hospitalier universitaire de Toulouse | 153 |
3 |
| MannKind Corporation | 521 |
3 |
| Universite Toulouse Iii-paul Sabatier | 214 |
3 |
| Ot4b | 8 |
3 |
| Acerus Pharmaceuticals USA, LLC | 9 |
3 |
| Other owners | 124 |